Early-Onset MASLD Risk Higher in Low-Birth-Weight Babies
TOPLINE: Babies with low birth weight or those who are small for gestational age (SGA) have a sixfold increased relative ...
TOPLINE: Babies with low birth weight or those who are small for gestational age (SGA) have a sixfold increased relative ...
TOPLINE: Nonalcoholic fatty liver disease (NAFLD) is an independent risk factor for precancerous colorectal adenomatous polyps in men and women, ...
TOPLINE: The indirect and direct costs of alcohol-associated liver disease (ALD) could sap the US economy of $880 billion from ...
Some clinicians say it's "confusing" and "ridiculous" to change the name and diagnostic criteria of an established liver disease, while ...
A contemporary trends analysis shows persistent racial and ethnic disparities in receipt of complex lifesaving procedures for decompensated cirrhosis, including ...
TOPLINE: Glucagon-like peptide-1 receptor agonist (GLP-1 RA) use lowers the risk for death, cardiovascular disease, decompensated cirrhosis, and liver failure ...
The US Food and Drug Administration (FDA) has rejected Intercept Pharmaceutical's second bid for approval of obeticholic acid (OCA) for ...
People with nonalcoholic fatty liver disease (NAFLD) are more likely to develop severe infections requiring hospitalization, according to findings from ...
The Food and Drug Administration has approved fezolinetant (Veozah), an oral medication for the treatment of moderate to severe hot ...
Statins have disease-modifying potential in people with non-cirrhotic chronic liver disease (CLD) by reducing the risk for progression to severe ...
© Pharma News Hubb All rights reserved.
Use of these names, logos, and brands does not imply endorsement unless specified. By using this site, you agree to the Privacy Policy and Terms & Conditions.
© 2022 Pharma News Hubb All rights reserved.